The best indicator for Charles River Laboratories (CRL)
We backtested 366 indicators across daily, weekly and hourly charts on real Charles River Laboratories (CRL) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Morning Star
On the daily chart, this is the strongest risk-adjusted edge we found for Charles River Laboratories (CRL) over ~25.9 years — beating buy-and-hold by 2.0% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Charles River Laboratories (CRL) — trailing buy-and-hold by 1.3% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Morning Star ✓ | Daily | 10.5% | 0.74 | -21.2% | 55.9% | 236 | 2.0% |
| 2 | Hammer ✓ | Daily | 7.0% | 0.67 | -32.4% | 64.1% | 145 | -1.5% |
| 3 | MA Envelope ✓ | Weekly | 9.6% | 0.49 | -65.1% | 72.3% | 65 | 1.1% |
| 4 | CCI ✓ | Daily | 8.4% | 0.47 | -76.2% | 77.2% | 127 | -0.1% |
| 5 | Camarilla Pivots ✓ | Weekly | 9.3% | 0.47 | -60.7% | 57.0% | 265 | 0.8% |
| 6 | Chande-Kroll Stop (fast) ✓ | Daily | 9.5% | 0.46 | -52.4% | 41.8% | 428 | 1.0% |
| 7 | Ehlers Cyber Cycle ✓ | Weekly | 8.2% | 0.46 | -53.7% | 51.4% | 140 | -0.2% |
| 8 | Deviation-Scaled MA ✓ | Daily | 8.3% | 0.45 | -55.0% | 45.0% | 687 | -0.1% |
| 9 | True Strength Index ✓ | Weekly | 7.6% | 0.45 | -46.3% | 53.7% | 54 | -0.8% |
| 10 | Pascal's Weighted MA ✓ | Daily | 6.8% | 0.43 | -41.5% | 46.5% | 342 | -1.7% |
| 11 | KAMA 200 Trend ✓ | Weekly | 8.3% | 0.43 | -46.3% | 45.0% | 20 | -0.2% |
| 12 | Fisher Center-of-Gravity ✓ | Daily | 6.5% | 0.42 | -51.9% | 49.5% | 683 | -2.0% |
| 13 | SMC: Liquidity Sweep ✓ | Weekly | 7.1% | 0.42 | -57.3% | 80.0% | 15 | -1.3% |
| 14 | Volume Flow Indicator ✓ | Daily | 7.3% | 0.41 | -59.3% | 42.0% | 50 | -1.1% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Charles River Laboratories (CRL), Morning Star on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.